| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.000.550 | 1.915.107 | 2.022.299 | 1.980.095 | 1.965.143 | 1.977.047 | 1.616.812 | - | - | - |
| Total Income - EUR | 2.008.087 | 1.920.016 | 2.024.579 | 1.985.093 | 1.978.602 | 1.991.721 | 1.755.237 | - | - | - |
| Total Expenses - EUR | 1.884.477 | 1.818.862 | 1.702.353 | 1.805.231 | 1.787.140 | 1.737.090 | 1.617.627 | - | - | - |
| Gross Profit/Loss - EUR | 123.610 | 101.154 | 322.227 | 179.862 | 191.462 | 254.631 | 137.611 | - | - | - |
| Net Profit/Loss - EUR | 115.511 | 84.969 | 289.633 | 155.834 | 170.078 | 240.806 | 119.389 | - | - | - |
| Employees | 20 | 0 | 20 | 15 | 12 | 0 | 11 | - | - | - |
Check the financial reports for the company - Olly Pharm Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 112.048 | 197.015 | 205.364 | 221.783 | 226.604 | 219.673 | 88.477 | - | - | - |
| Current Assets | 569.997 | 966.748 | 897.678 | 957.906 | 850.203 | 1.366.011 | 1.215.524 | - | - | - |
| Inventories | 64.203 | 111.150 | 300.108 | 324.796 | 546.749 | 739.414 | 413.680 | - | - | - |
| Receivables | 425.030 | 634.827 | 294.915 | 517.315 | 279.946 | 494.530 | 789.830 | - | - | - |
| Cash | 80.764 | 220.771 | 302.655 | 115.795 | 23.507 | 132.067 | 12.015 | - | - | - |
| Shareholders Funds | 154.730 | 238.122 | 523.725 | 620.523 | 588.927 | 818.567 | 435.336 | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | - | - | - |
| Debts | 527.315 | 925.641 | 579.317 | 559.403 | 487.918 | 767.154 | 868.702 | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Olly Pharm Bio S.r.l.